A 25 Week, Open Label Study to Determine the Effects of Nebivolol When Added to Hydrochlorothiazide on Diastolic Function and Arterial Stiffness in African Americans With Hypertension.

Trial Profile

A 25 Week, Open Label Study to Determine the Effects of Nebivolol When Added to Hydrochlorothiazide on Diastolic Function and Arterial Stiffness in African Americans With Hypertension.

Completed
Phase of Trial: Phase II

Latest Information Update: 04 May 2011

At a glance

  • Drugs Hydrochlorothiazide; Nebivolol
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms NASAA
  • Sponsors InVasc Therapeutics
  • Most Recent Events

    • 06 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Nov 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top